This annual conference is now established as a key event in the sector to hear the very latest thinking from senior experts and leading speakers from the MHRA, the life science industry, the Office for Life Sciences, the Department of Health and Social Care, the National Institute for Health and Care Excellence (NICE), notified bodies, the European Medicines Agency (EMA), research charities and patient organisations, as well as to network and contribute to the discussions.
This conference will be themed on Collaborative Working in the UK, Driving Innovation Forward and hosts an impressive line up of speakers.
- Brexit: Business continuity planning and the UK regulatory environment
- Working together in the accelerated access pathway for breakthrough therapies and technologies
- Drug device combinations – Supporting innovation and addressing regulatory challenges
- Real world evidence – Sources for data collection and role in regulatory decision-making